You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematologic disorders

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

    Recruiting
    • Hematologic Disorders
    • Miltenyi CliniMACS® CD34 Reagent System
    • Aurora, Colorado
      University of Colorado
    Feb 22, 2022

    Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

    Not yet recruiting
    • Stem Cell Transplantation
    • Houston, Texas
      M D Anderson Cancer Center
    May 4, 2022

    SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

    Recruiting
    • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
    • COVID-19 serology IgG
    • Detroit, Michigan
      Henry Ford Health System
    Jul 19, 2022

    Study of Non-Neoplastic Hematologic Disorders

    Recruiting
    • Hematologic Disorder
    • +8 more
      • Phoenix, Arizona
      • +9 more
      May 18, 2022

      Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

      Recruiting
      • Sickle Cell Disease
      • +4 more
      • Blood and Marrow Transplant
      • Minneapolis, Minnesota
        Masonic Caner Center at University of Minnesota
      May 23, 2022

      Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)

      Completed
      • Multiple Myeloma
      • Amyloidosis
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 24, 2021

      Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)

      Recruiting
      • Sickle Cell Disease
      • Famotidine 400 mg/50 mL
      • Paris, France
        Necker - Enfants malades Hospital; Department of Pediatrics and
      Oct 10, 2022

      Hematology Biobank : Invitro Study of Blood Disorders

      Recruiting
      • Hematological Disorders
        • Bronx, New York
          Montefiore Medical Center
        Nov 14, 2022

        Immunomodulatory Molecules in Hematologic Disorders and Healthy

        Completed
        • Hematologic Diseases
        • Healthy Volunteers
        • Isolation of genomic DNA
        • San Antonio, Texas
        • +1 more
        Jul 14, 2021

        Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

        Active, not recruiting
        • Hematologic Neoplasm
        • Neoplasms
        • Gainesville, Florida
        • +2 more
        Jan 12, 2023

        Hematological Disorders Associated With COVID-19 Infection

        Completed
        • Hematological Condition With COVID19
          • Assiut, Egypt
            Facility of medicine
          Jan 6, 2023

          Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

          Not yet recruiting
          • Immune System Diseases
          • +15 more
          • observational cohort study
          • (no location specified)
          Jul 23, 2023

          Examining the Experiences of Children With Blood Disorders

          Recruiting
          • Blood Disease
          • +4 more
            • Dallas, Texas
              The University of Texas Southwestern Medical Center
            Jan 16, 2023

            Blood and/or Bone Marrow for Investigation and Characterization

            Recruiting
            • Leukemia
              • Worcester, Massachusetts
                University of Massachusetts Medical School
              Feb 2, 2022

              Pathogenesis of Hematologic Malignancies

              Enrolling by invitation
              • Acute Leukemia
              • +3 more
              • blood draw, bone marrow procedure, or tissue biopsy
              • Portland, Oregon
                OHSU Knight Cancer Institute
              Sep 9, 2022

              Screening for Hematology Branch Protocols

              Enrolling by invitation
              • Hematologic Disease and Disorders
              • +2 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Jan 28, 2023

                AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

                Recruiting
                • AML
                • +8 more
                • New York, New York
                  Memorial Sloan Kettering Cancer Center
                May 13, 2022

                Spectrum of Hematological Disorders in Pediatrics

                Not yet recruiting
                • Pancytopenia
                • CBC.with with differential Peripheral smear
                • (no location specified)
                Jul 22, 2022

                Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

                Terminated
                Has Results
                • Non-Malignant Hematologic Disorders
                • New York, New York
                  Memorial SloanKettering Cancer Center
                Mar 1, 2021

                Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

                Active, not recruiting
                • Acute Myeloid Leukemia
                • +17 more
                • Tampa, Florida
                  H. Lee Moffitt Cancer Center & Research Institute
                Jan 10, 2023

                Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

                Completed
                Has Results
                • Myeloproliferative Disorders
                • +4 more
                • T-cell replete PBPC allograft
                • +3 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center, 9000 Rockville Pi
                Oct 12, 2022

                Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

                Recruiting
                • Acute Myeloid Leukemia
                • +3 more
                • Orange City, Florida
                • +7 more
                Oct 31, 2022

                Venetoclax Tablets Crushed and Dissolved Into a Solution

                Not yet recruiting
                • Hematologic Malignancy
                • +18 more
                • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
                • Cincinnati, Ohio
                  Cincinnati Children's Hospital Medical Center
                Nov 8, 2023

                Cancer Trial in Denver (Creative Arts Therapy)

                Active, not recruiting
                Has Results
                • Cancer
                • Creative Arts Therapy
                • Denver, Colorado
                  Children's Hospital Colorado
                Jun 8, 2022